Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ZOPICLONE | 5MG | TABLET | Actual shortage | 2023-02-02 | 2024-02-01 | 183386 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183389 |
ACT FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-02-02 | 2023-10-04 | 183392 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-02-02 | 2023-07-12 | 183395 |
TEVA-LISINOPRIL/HCTZ (TYPE Z) | 25MG 20MG | TABLET | Resolved | 2023-02-02 | 2023-02-16 | 183398 |
TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-02-02 | 2023-10-06 | 183404 |
TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183407 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183410 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183416 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-02-02 | 2023-02-09 | 183425 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184171 |
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184177 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184180 |
TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184183 |
ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-02-09 | 2023-07-05 | 184195 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184198 |
TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-02-09 | 2023-07-06 | 184201 |
ACT AMLODIPINE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184204 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |